Treatment of varicose veins, international consensus on which major complications to discuss with the patient: A Delphi study

Phlebology
Sylvana Ml de MikDirk T Ubbink

Abstract

To reach consensus on which complications of varicose vein treatments physicians consider major or minor, in order to standardize the informed consent procedure and improve shared decision-making. Using the e-Delphi method, expert physicians from 10 countries were asked to rate complications as "major" or "minor" on a 5-point Likert scale. Reference articles from a Cochrane review on varicose veins were used to compose the list of complications. Participating experts reached consensus on 12 major complications: allergic reaction, cellulitis requiring intravenous antibiotics/intensive care, wound infection requiring debridement, hemorrhage requiring blood transfusion/surgical intervention, pulmonary embolism, skin necrosis requiring surgery, arteriovenous fistula requiring repair, deep venous thrombosis, lymphocele, thermal injury, transient ischemic attack/stroke, and permanent discoloration. An international consensus was reached about what physicians consider to be major complications of varicose vein treatments. This consensus may assist in standardizing the information physicians discuss with patients prior to varicose vein treatment.

References

May 22, 2002·Journal of Vascular Surgery·Elliot L ChaikofUNKNOWN Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Assoc
Mar 22, 2003·Annals of the Royal College of Surgeons of England·P L McManus, K E Wheatley
Oct 21, 2004·The Cochrane Database of Systematic Reviews·N AdhikariM O Meade
Oct 21, 2004·The Cochrane Database of Systematic Reviews·K A RigbyJ A Michaels
Feb 6, 2007·Journal of the Royal Society of Medicine·Owen A Anderson, I Mike J Wearne
Sep 7, 2007·Journal of Vascular and Interventional Radiology : JVIR·Sanjoy KunduUNKNOWN Society of Intervnetional Radiography
Mar 30, 2010·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A M KnopsA Goossens
Mar 31, 2010·Quality & Safety in Health Care·P Massó GuijarroC Aibar
Oct 5, 2010·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P PronkC J van Vlijmen-van Keulen
May 26, 2011·Journal of Vascular Surgery·Carlos H TimaranFred Littooy
Apr 1, 2014·The Cochrane Database of Systematic Reviews·Tim TaylorNathan Leon Pace
Jul 31, 2014·The Cochrane Database of Systematic Reviews·Craig NesbittGerard Stansby
Oct 8, 2014·Database : the Journal of Biological Databases and Curation·Gregory Vey, Trevor C Charles
Mar 18, 2015·BMJ : British Medical Journal·Daniel K Sokol
Jun 3, 2015·Patient Safety in Surgery·Alexandra E Page

❮ Previous
Next ❯

Citations

Jul 17, 2021·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Kilsoo Yie

❮ Previous
Next ❯

Software Mentioned

DISCOVAR
SPSS Statistics
SurveyMonkey

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.